{"id":"F2008L01091","name":"Therapeutic Goods Act 1989 - Order under subsection 3(1) – Definition of British Pharmacopoeia (09/04/2008)","slug":"therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-09-04-2008","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":73242,"registerId":"commonwealth-F2008L01091-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods Act 1989 - Order under subsection 3(1) – Definition of British Pharmacopoeia (09/04/2008)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n![](image.001.png)\n\n \n\n \n\nTHERAPEUTIC GOODS ACT 1989\n\n \n\nORDER UNDER SUBSECTION 3(1) – DEFINITION OF BRITISH PHARMACOPOEIA\n\n \n\nI, ROHAN HAMMETT, delegate of the Minister for Health and Ageing for the purposes of the exercise of the Minister’s power under the definition of “British Pharmacopoeia” in subsection 3(1) of the Therapeutic Goods Act 1989 (“the Act”) and acting under that provision, HEREBY SPECIFY that on and from 1 July 2008 the definition of “British Pharmacopoeia” in the Act shall be the British Pharmacopoeia 2008.\n\n \n\n \n\nDated this      9th    day of April 2008\n\n \n\n \n\n \n\n \n\n \n\n \n\nROHAN HAMMETT\n\nNational Manager\n\nTherapeutic Goods Administration\n\n(Delegate of the Minister for Health and Ageing)\n\n \n","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1584},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This Order performs exactly the function indicated by its title—updating a definitional reference to a new edition of a pharmacopoeia. It does not expand beyond the original purpose of ensuring the Therapeutic Goods Act references current pharmaceutical standards."},"complexity_factors":["Single sentence operative provision with no subsections or paragraphs","Zero defined terms within the instrument itself","No conditional logic, exceptions, or procedural requirements","No internal cross-references to other parts of the Act"],"plain_english_summary":"This Order amends the Therapeutic Goods Act’s reference to the British Pharmacopoeia to mean the 2008 edition (effective 1 July 2008). It ensures manufacturers, importers, the TGA and healthcare professionals use that edition’s quality standards and test methods when assessing medicines supplied in Australia."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-09-04-2008","history":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-09-04-2008/history","analysis":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-09-04-2008/analysis","conflicts":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-09-04-2008/conflicts","importantCases":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-09-04-2008/important-cases","documents":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-09-04-2008/documents"}}